• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Smooth Sailing with DOACs: Navigating Anticoagulant Chartered Waters

Program Type

OnDemand

Credits

1 Contact Hour(s)

Release Date

Sunday, February 14, 2021

Offline Date:

Tuesday, February 14, 2023

ACPE Expiration Date

Monday, August 14, 2023

Target Audience

Nurse, Pharmacist

Cost

$4.00

  • Overview

    Direct oral anticoagulants (DOACs) are recognized by guidelines as first-line options for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalular atrial fibrillation.  The use of DOACs is wide-spread, and it is challenging to ensure patient safety as each agent has slightly different pharmacokinetic considerations with their use.  This program will address safety and efficacy with each agent, initial recommendations for dosing and adjustments based on renal considerations, drug interactions, and age and weight.  Common risk factors for bleeding will be identified as well as options in support of the management of bleeding, if it should occur, are proposed. 

    Handouts

    Slide Document:   20177H01_2pp.pdf
    Slide Document:   20177H01_6pp.pdf

    Financial Support By

    PharmCon
  • Nurse

    Differentiate among direct acting anticoagulants available for the treatment of non-valvular atrial fibrillation and venous thromboembolism.
    Determine appropriate individualized treatment for patients based upon current literature and evidence based guidelines.
    Identify appropriate modifications of direct acting anticoagulants such as dose adjustments or optimization of therapy in patients at risk for diminished efficacy or bleeding.


    Pharmacist

    Differentiate among direct acting anticoagulants available for the treatment of non-valvular atrial fibrillation and venous thromboembolism.
    Determine appropriate individualized treatment for patients based upon current literature and evidence based guidelines.
    Identify appropriate modifications of direct acting anticoagulants such as dose adjustments or optimization of therapy in patients at risk for diminished efficacy or bleeding.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-20-177-H01-N

    Pharmacist 0798-0000-20-177-H01-P

    ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.